<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Fluidigm Corporation

    Fluidigm Corporation

    Fluidigm (NASDAQ:FLDM) is an industry-leading biotechnology tools provider with a ...

    Fluidigm (NASDAQ:FLDM) is an industry-leading b...

    Filing Type:    PU
    Bioclonetics Immunotherapeutics, Inc.

    Bioclonetics Immunotherapeutics, Inc.

    BioClonetics Immunotherapeutics is a biotechnology company with a proprietary meth...

    BioClonetics Immunotherapeutics is a biotechnol...

    Amount Raised:    $255,600
    Fundraising Status:    EC
    Filing Type:    CF

    Esembly Inc.

    Esembly Inc. sells organic & sustainable cloth diapers.

    Esembly Inc. sells organic & sustainable cloth ...

    Filing Type:    CF
    JanOne Inc.

    JanOne Inc.

    JanOne, formerly Appliance Recycling Centers of America, Inc., and subsidiaries, i...

    JanOne, formerly Appliance Recycling Centers of...

    Filing Type:    PU
    Ocular Therapeutix, Inc.

    Ocular Therapeutix, Inc.

    Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on ...

    Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a bi...

    Filing Type:    PU
    Eagle Pharmaceuticals, Inc.

    Eagle Pharmaceuticals, Inc.

    Eagle is a specialty pharmaceutical company working to advance safe and efficient ...

    Eagle is a specialty pharmaceutical company wor...

    Filing Type:    PU
    BioXcel Therapeutics, Inc.

    BioXcel Therapeutics, Inc.

    BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused o...

    BioXcel Therapeutics, Inc. is a clinical stage ...

    Filing Type:    PU
    DelMar Pharmaceuticals, Inc.

    DelMar Pharmaceuticals, Inc.

    DelMar Pharmaceuticals is a biopharmaceutical company focused on the development a...

    DelMar Pharmaceuticals is a biopharmaceutical c...

    Filing Type:    PU
    Marker Therapeutics, Inc.

    Marker Therapeutics, Inc.

    We are a clinical-stage immuno-oncology company specializing in the development an...

    We are a clinical-stage immuno-oncology company...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.